Pharma-Bio Serv (PBSV) Cash from Operations (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Cash from Operations came in at -$365311.0 in Q2 2026, down 21.13% on a YoY basis from -$463171.5 in Q2 2025, and up 6.36% quarter-over-quarter from -$390139.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Cash from Operations (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Cash from Operations for 17 consecutive years, with -$365311.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Operations fell 21.13% year-over-year to -$365311.0; the trailing twelve-month figure through Apr 2026 stood at -$239260.0 (up 81.92% YoY), and the FY2025 full-year result was -$214886.0, up 62.08% from the prior year.
- Cash from Operations grew to -$365311.0 in Q2 2026 per PBSV's latest filing, from -$390139.0 in the prior quarter.
- Across five years, Cash from Operations topped out at $1.1 million in Q3 2022 and bottomed at -$700744.0 in Q2 2024.
- Historically, Cash from Operations has averaged $52576.7 across 5 years, with a median of -$85841.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations surged 367.68% in 2023, then plunged 180.18% in 2024.
- Over 5 years, Cash from Operations stood at $260091.0 in 2022, then rose by 18.59% to $308436.0 in 2023, then slumped by 74.57% to $78425.0 in 2024, then soared by 256.6% to $279666.0 in 2025, then plunged by 230.62% to -$365311.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered -$365311.0, -$390139.0, and $279666.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 3.79 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 160.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 398.29 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 228.94 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 281.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 72.44 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 296.68 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 152.29 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 108.65 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -365,311.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -365,311.00 |
| Jan 31, 2026 | -390,139.00 |
| Oct 31, 2025 | 279,666.00 |
| Jul 31, 2025 | 236,524.00 |
| Apr 30, 2025 | -301,590.00 |
| Jan 31, 2025 | -429,486.00 |
| Oct 31, 2024 | 78,425.00 |
| Jul 31, 2024 | -670,327.00 |
| Apr 30, 2024 | -700,744.00 |
| Jan 31, 2024 | 725,945.00 |
| Oct 31, 2023 | 308,436.00 |
| Jul 31, 2023 | 956,765.00 |
| Apr 30, 2023 | -250,107.00 |
| Jan 31, 2023 | 875,866.00 |
| Oct 31, 2022 | 260,091.00 |
| Jul 31, 2022 | 1.11 Mn |
| Apr 30, 2022 | -446,285.00 |
| Jan 31, 2022 | -327,202.00 |
| Oct 31, 2021 | 960,350.00 |
| Jul 31, 2021 | 441,724.00 |